Shanghai Qilu Pharmaceutical Research and Development Center LTD

Works in Dermatology · Genetic & rare · GI & liver · Immunology · Infectious disease · Musculoskeletal · Ophthalmology

Shanghai Qilu Pharmaceutical Research and Development Center LTD is a clinical trial sponsor. It has 7 active clinical trials with 780 planned participants, across 7 therapeutic areas.

Trial track record · since 2021

7Active trials780 planned participants
0Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

Pipeline · 7 active trials

StageTrialStatus

Questions about Shanghai Qilu Pharmaceutical Research and Development Center LTD

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-04.

Approve Suite is not affiliated with Shanghai Qilu Pharmaceutical Research and Development Center LTD.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.